DNB CTVS Questions- December 2010


1.Enumerate deleterious effects of hypothermia on organ systems during      cardiopulmonary bypass. 10
2. Development of aortic arch with brief discussion on vascular ring. 10
3.  Classification o f mediastinum. Enumerate common tumours of each area. 10
4. process and criteria of sample size selection for a clinical study. 10
5. draw a labeled diagram and discuss the circulation changes that occur at the time of birth and their pathophysiological significance. 10
6. discuss in brief with labeled diagrams various surgical modalities in the management of  atrial fibrillation. 10
7.  enumerate neuroprotective strategies and their use in various surgical operations. Highlight use of one strategy of your choice. 10
8. diagnosis and management of heparin induced thrombocytopenia. 10
9. development of left superior vena cava and its implications during cardiac surgery. 10
10. diagnosis and cardiovascular manifestations of Marfan’s disease. 10
1. Aetiopathogenesis of thoracic outlet syndrome. 10
2. Presentation and surgical management of sequestration of lung. 10
3. Classification and surgical management (in brief) of tricuspid atresia.10
4. Classification and surgical management (in brief) of truncus arteriosus. 10
5. Pulmonary vascular disease and its investigation and grading.10
6. Mitral Valve Replacement – advantages of total chordal preservation and comparison with other techniques. 10
7. Coronary artery bypass- comparison of radial, saphenous vein and internal thoracic artery in term of histopathology and long term outcome. 10
8. Classification of thoraco-abdominal aortic aneurysms and role of endovascular interventions in their management. 10
9. Explain with diagram different surgical procedures for the management of small aortic root and comparative chart of their advantages and disadvantages. 10
10. Basic component and modifications of myocardial protection. 10

1. Cell sources for cardiac tissue engineering. 10
2. Centrifugal pump: advantages and disadvantages of its use in assisted circulation. 10
3. “No flow” phenomenon in myocardial ischemia.10
4. Computed tomography in re-operative cardiac surgeries and its role in pre operative planning and surgical guidance. 10
5. Role of hybrid operative interventions in cardiovascular surgery. 10
6. Current status  of cardiac transplantation. 10
7. Power source, current status and future development of artificial heart. 10
8. Newer oral anticoagulants and their role in DVT, AF, and Cardiological interventions. 10
9. Advantages and disadvantages of Virtual bronchoscopy. 10
10. Percutaneous valve implantation- in various positions, evolutions and future direction. 10

DNB CTVS Questions- December 2011

DECEMBER 2011    

1. Describe surgical anatomy of tracheo-bronchial tree. 10
2. a. Enumerate constituents and various types of cardioplegic solutions.        b. Functions of those constituents  c. Advantages and disadvantages of blood Vs crystalloidcardioplegic solution 5+2+3
3. a. Embryology of transposition of great arteries. b. Coronary arterial anomalies 5+5
4. Briefly discuss diaphragmatic rupture under the following headings:            a. Clinical presentation and signs   b. Investigations    c. Treatment 3+4+3
5. Discuss in brief solitary pulmonary nodule under the following headings:    a. Differential diagnosis       b. lnvestigations      c. Management algorithms (flowchart)3+3+4
6. Hemolysis during cardiopulmonary bypass: Causes, Systemic effects, management and recent advances 3+3+2+2
7. Discuss in brief cardiac tissue engineering under the following headings:     a. Donor cell types        b. Delivery routes, advantages and disadvantages       c. Clinical applications 3+4+3
8. 64 slice MDCT angiography: a. Comparison with conventional angiography   b. Preoperative planning of primary and re-operative surgeries                      c. Role in congenital heart diseases           d. Role in coronary artery disease 2+2+3+3
9. Describe the causes, risk assessment and neuroprotective strategies of cerebral injury during CPB. 3+3+4
10. Briefly discuss the role of nitric oxide (NO) in cardiac surgery under the following headings:   a. Physiological basis of use of NO       b. Indications for its use      c. Modes of administration with dosing         d. Precautions, safety issues related to its use’in ICU 3+2+2+3

1. Discuss briefly the spinal cord protection during thoracic aortic surgery under the following headings:  a. Blood supply and collateral circulation.     b. Methods of ischemia detection.      c. Preventive strategies for spinal cord protection.3+3+4
2. Benign thymic tumours: Classification, role of thymectomy in myasthenia gravis, and effects/complications after thymectomy. 3+4+3
3. a. Causes and types of post-operative cardiac dysarrhythmias.                       b. Univentricular Vs biventricular pading.          c. Post-operative heart blocks and roles of temporary atrialor A-V sequential pacing. 3+3+4
4. a. Treatment for pectus excavatum        b. Physiological effects of pectus excavatum           c. Treatment for pectus carinatum           d. Physiological effects of pectus carinatum. 3+2+3+2
5. a. Briefly discuss techniques of total chordal preservation;   and                     b. Advantages of chordal preservation and long term effects on reverse left ventricular remodeling. 6+4
6. Double outlet right ventricle: Anatomic definition, classification, investigations, management (surgical) and results. 1+3+2+3+1
7. Tricuspid valve anomalies: Types of congenital / acquired anomalies, indications of surgery and types of repair. 3+2+5
8. Discuss briefly your reasons for choice of valve prosthesis and /or procedure:      a. In a patient with end stage renal disease (ESRD)                   b. In a pediatric patient (less than or equal to 12 years)                                    c. In a lady in child bearing age .   d. Non rheumatic mitral valve disease in adult in 30’s.                                       e. Rheumatic mitral and aortic valve disease in an adult (less than or equal to 45years). 2+2+2+2+2
9. Enumerate types of congenital arch anomalies. Discuss in brief their presentation, investigations, management and results. 2+2+2+2+2
10. a. Hydatid cyst of lung: Diagnosis and management  2+3      b. Pericardial cysts: Diagnosis and management 2+3

1. Describe current status of extra-corporeal membrane oxygenation (ECMO) under the following headings:   a. Indications of use     b. Physiological basis    c. Equipment required for setting up                              d. Method of weaning                     e. Complications  2+2+2+2+2
2. Discuss TNM classification for lung carcinoma in relation to:     a. Recent recommendations in TNM criteria         b. Choice of treatment based on TNM staging            c. Results of treatments in various TNM stages. 3+3+4
3. a. CHOUSSATS’ criteria for single ventricle         b. Modified Fontan criteria  c. Physiological basis of Fontan’s circulation           d. Advantages of one and half ventricle repair 3+2+3+2
4. a. Design of SYNTAX trial                             b. Outcomes of SYNTAX trial                                c. lmpact of SYNTAX scoring system on current practice of coronary bypass surgery. 5+3+2
5. Discuss cardiopulmonary bypass strategies in a patient of  Heparin Induced Thrombocytopenia (HlT) in terms of:        a. Platelet pretreatment  b. Platelet inhibition              c. Alternate drugs for anticoagulation 3+3+4
6. Bosentan: Mechanism of action, pharmacokinetics, indications, side effects and current status of its use. 2+2+2+2+2
7. Percutaneous Left Ventricular Assist Devices (P-LVADs):  a. Types of             P-LVADs available,                      b. lt’s role in bridge to transplantations                        c. Systemic deleterious effects on various organ systems. 4+4+3
8. Discuss in brief methods to stop anastomotic leaks from a vascular anastomosis under the following headings:               a. Names of various devises/substances  b. Advantages and disadvantages of their uses              c. Use of Gel-plugs; mechanism of action and contraindication of its usage. 3+3+4
9. Modified Vs conventional ultrafiltration: Difference between them, indications and advantages/disadvantages 3+3+4
10. Discuss transannular patch in Tetralogy of Fallots under the following heads:       a. Indications and contraindications           b. Advantages and disadvantages       c. Surgical technique               d. Role of homografts Vs heterografts as replacement to   transannular patch  3+3+1+3